4.7 Review

Breast milk microbiota: A review of the factors that influence composition

Journal

JOURNAL OF INFECTION
Volume 81, Issue 1, Pages 17-47

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.jinf.2020.01.023

Keywords

Microbiome; Diversity; Delivery; Caesarean; GBS; Antibiotics; BMI; Probiotics; Smoking; Diet

Funding

  1. European Society of Paediatric Infectious Diseases

Ask authors/readers for more resources

Breastfeeding is associated with considerable health benefits for infants. Aside from essential nutrients, immune cells and bioactive components, breast milk also contains a diverse range of microbes, which are important for maintaining mammary and infant health. In this review, we summarise studies that have investigated the composition of the breast milk microbiota and factors that might influence it. We identified 44 studies investigating 3105 breast milk samples from 2655 women. Several studies reported that the bacterial diversity is higher in breast milk than infant or maternal faeces. The maximum number of each bacterial taxonomic level detected per study was 58 phyla, 133 classes, 263 orders, 596 families, 590 genera, 1300 species and 3563 operational taxonomic units. Furthermore, fungal, archaeal, eukaryotic and viral DNA was also detected. The most frequently found genera were Staphylococcus, Streptococcus Lactobacillus, Pseudomonas, Bifidobacterium, Corynebacterium, Enterococcus, Acinetobacter, Rothia, Cutibacterium, Veillonella and Bacteroides. There was some evidence that gestational age, delivery mode, biological sex, parity, intrapartum antibiotics, lactation stage, diet, BMI, composition of breast milk, HIV infection, geographic location and collection/feeding method influence the composition of the breast milk microbiota. However, many studies were small and findings sometimes contradictory. Manipulating the microbiota by adding probiotics to breast milk or artificial milk offers an exciting avenue for future interventions to improve infant health. (C) 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pediatrics

Should children be vaccinated against COVID-19?

Petra Zimmermann, Laure F. Pittet, Adam Finn, Andrew J. Pollard, Nigel Curtis

Summary: The debate over whether all children under 12 should be vaccinated against COVID-19 continues, with considerations including the relatively low risk of acute COVID-19 in children and the complexity of weighing the risks and benefits of vaccination. Other factors to consider include protection from long-term consequences, population-level impacts, vaccine supply, cost, and avoiding quarantine measures. Ongoing evaluation is needed due to the emergence of new variants of concern.

ARCHIVES OF DISEASE IN CHILDHOOD (2022)

Article Pediatrics

Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study

Anita Uka, Michael Buettcher, Sara Bernhard-Stirnemann, Yves Fougere, Dehlia Moussaoui, Lisa Kottanattu, Noemie Wagner, Petra Zimmermann, Nicole Ritz

Summary: This study confirms that COVID-19 is mostly mild in children, with fever, rash, and comorbidities associated with higher admission rates. Continuous observation is crucial for further understanding pediatric COVID-19, guiding therapy, and evaluating the necessity of vaccination in children.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Review Pediatrics

Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment - a systematic review

Michele Keller, Laure F. Pittet, Petra Zimmermann

Summary: Research shows that vaccination in children with JARD on immunosuppressive treatment may lead to reduced immunogenicity and lower vaccine responses, but overall vaccines are still safe and should be encouraged. It is important to stress the completion of vaccination schedules for these children.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Review Infectious Diseases

Antibiotic exposure and adverse long-term health outcomes in children: A systematic review and meta-analysis

Quynh A. Duong, Laure F. Pittet, Nigel Curtis, Petra Zimmermann

Summary: This study systematically searched and analyzed observational studies, and found associations between antibiotic exposure and adverse long-term health outcomes in children. These outcomes include atopic dermatitis, allergic symptoms, food allergies, allergic rhinoconjunctivitis, wheezing, asthma, increased weight gain or overweight, obesity, juvenile idiopathic arthritis, psoriasis, autism spectrum disorders, and neurodevelopment disorders. The results suggest the need for careful antibiotic stewardship to avoid potential negative health outcomes.

JOURNAL OF INFECTION (2022)

Editorial Material Pediatrics

Orf Virus Infection: Ecthyma Contagiosum

Caroline Tobler, Celine Ritter-Schenk, Petra Zimmermann

JOURNAL OF PEDIATRICS (2022)

Article Immunology

Why Does the Severity of COVID-19 Differ With Age? Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection

Petra Zimmermann, Nigel Curtis

Summary: The age-related difference in the severity of COVID-19 is most likely due to differences in innate, adaptive, and heterologous immunity, as well as endothelial and clotting function. Children have a stronger and faster innate immune response to SARS-CoV-2, while adults can have an overactive and less effective response. Exposure to other viruses and vaccines in children may contribute to cross-reactive antibodies and T cells against SARS-CoV-2.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Article Pediatrics

Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial

Tatjana Welzel, Andrew Atkinson, Nina Schobi, Maya C. Andre, Douggl G. N. Bailey, Geraldine Blanchard-Rohner, Michael Buettcher, Serge Grazioli, Henrik Koehler, Marie-Helene Perez, Johannes Truck, Federica Vanoni, Petra Zimmermann, Carlos Sanchez, Julia A. Bielicki, Luregn J. Schlapbach

Summary: This study aimed to evaluate the effectiveness of intravenous methylprednisolone compared with intravenous immunoglobulins in children with PIMS-TS. The results showed no significant difference in the length of hospital stay between the methylprednisolone group and the immunoglobulin group, but fewer patients in the methylprednisolone group required respiratory support.

LANCET CHILD & ADOLESCENT HEALTH (2023)

Editorial Material Pediatrics

A diagnostic algorithm for children presenting with peripheral facial nerve palsy and inconclusive diagnosis of neuroborreliosis

Ines Mack, Malte Vasconcelos, Nicole Ritz, Petra Zimmermann

ACTA PAEDIATRICA (2023)

Article Pediatrics

Metagenomics analysis of the neonatal intestinal resistome

Stefano Leo, Omer F. Cetiner, Laure F. Pittet, Nicole L. Messina, William Jakob, Laurent Falquet, Nigel Curtis, Petra Zimmermann

Summary: This study analyzed the resistome in stool samples collected from 390 healthy, term-born neonates at 1 week of age. It found a high abundance and variety of antibiotic resistance genes (ARGs) in the neonatal intestine, even in the absence of direct antibiotic exposure. The resistome composition was strongly associated with the phylogenetic composition and other factors such as delivery mode, gestational age, birth weight, feeding method, and antibiotics in the last trimester of pregnancy.

FRONTIERS IN PEDIATRICS (2023)

Editorial Material Immunology

The immunological interplay between vaccination and the intestinal microbiota

Petra Zimmermann

NPJ VACCINES (2023)

Article Pediatrics

International Pediatric COVID-19 Severity Over the Course of the Pandemic

Yanshan Zhu, Flavia Jacqueline Almeida, J. Kenneth Baillie, Asha C. Bowen, Philip N. Britton, Martin Eduardo Brizuela, Danilo Buonsenso, David Burgner, Keng Yih Chew, Kulkanya Chokephaibulkit, Cheryl Cohen, Stephania A. Cormier, Nigel Crawford, Nigel Curtis, Camila G. A. Farias, Charles F. Gilks, Anne von Gottberg, Diana Hamer, Daniel Jarovsky, Waasila Jassat, Ana Rita Jesus, Lisa S. Kemp, Benjawan Khumcha, Georgina McCallum, Jessica E. Miller, Rosa Morello, Alasdair P. S. Munro, Peter J. M. Openshaw, Srivatsan Padmanabhan, Wanatpreeya Phongsamart, Gary Reubenson, Nicole Ritz, Fernanda Rodrigues, Supattra Rungmaitree, Fiona Russell, Marco A. P. Safadi, Christoph Saner, Malcolm G. Semple, Daniella Gregoria Bomfim Prado da Silva, Laise Marine Moura de Sousa, Marilia Diogo Moco Souza, Kirsten Spann, Sibongile Walaza, Nicole Wolter, Yao Xia, Daniel K. Yeoh, Heather J. Zar, Petra Zimmermann, Kirsty R. Short

Summary: This study investigates the impact of SARS-CoV-2 variants on the severity of COVID-19 in hospitalized children. The results suggest that while ICU admissions decrease across all age groups, ventilatory and oxygen support generally do not decrease significantly over time in children aged younger than 5 years.

JAMA PEDIATRICS (2023)

Review Public, Environmental & Occupational Health

Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe

Antoni Soriano-Arandes, Ana Brett, Danilo Buonsenso, Louise Emilsson, Isabel de la Fuente Garcia, Despoina Gkentzi, Otto Helve, Kasper P. Kepp, Maria Mossberg, Taulant Muka, Alasdair Munro, Cihan Papan, Aida Perramon-Malavez, Frederik Schaltz-Buchholzer, Pierre R. Smeesters, Petra Zimmermann

Summary: This review analyzes the differences in epidemiology, policies, mitigation trade-offs, and outcomes between children and adults during the SARS-CoV-2 pandemic. It discusses the amount of mitigation children should bear and the uncertainties surrounding their role in transmission.

FRONTIERS IN PUBLIC HEALTH (2023)

Article Medicine, General & Internal

Cardiac involvement in children with paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): data from a prospective nationwide surveillance study

Anita Uka, Sabrina Bressieux-Degueldre, Michael Buettcher, Lisa Kottanattu, Margerita Plebani, Anita Niederer-Loher, Nina Schobi, Michael Hofer, Julie Tomasini, Johannes Truck, Reto Villiger, Noemie Wagner, Daniela Wuetz, Nicole Ritz, Petra Zimmermann

Summary: This study found that cardiac complications are common in children with PIMS-TS and may worsen during hospitalization. Regardless of the initial severity, resolution of left ventricular systolic dysfunction is observed, often rapidly during hospitalization. Most coronary artery abnormalities regress, but some are still present at follow-up, emphasizing the need for prolonged cardiac evaluation after PIMS-TS.

SWISS MEDICAL WEEKLY (2023)

Article Medicine, General & Internal

Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study

Petra Zimmermann, Anita Uka, Michael Buettcher, Yves Fougere, Margherita Plebani, Christa Relly, Hanna Schmid, Nicole Ritz

Summary: This study presents nationwide epidemiological data, clinical characteristics, treatment, and outcomes of neonates with symptomatic SARS-CoV-2 infection in Switzerland. The majority of neonates had mild symptoms and required short hospital stays.

SWISS MEDICAL WEEKLY (2022)

Article Medicine, General & Internal

Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study

Paola A. Rouge Elton, Patrick A. Schmitt, Mohamed Faouzi, Petra Zimmermann, Celine Ritter Schenk

Summary: The main risk factor for seropositivity in children under the age of 6 is having household members who have tested positive for SARS-CoV-2. However, family size is not associated with increased risk of infection in children of this age group. Additionally, extra-familial care does not increase the risk of children becoming SARS-CoV-2 seropositive, nor does the number of contacts present in such care settings.

SWISS MEDICAL WEEKLY (2022)

No Data Available